Abstract

Background: Liver abscess is an important but relatively rare disease in children. This study investigated the clinical characteristics of eligible patients at a referral tertiary center over the past two decades.Method: A 20-year retrospective study (January 2000–December 2019) enrolled 38 children diagnosed with liver abscess. Demographic data; clinical features; laboratory, imaging, and microbiological findings; management strategy; and outcomes were reviewed from the patients' medical records.Results: Thirty-eight cases of pyogenic liver abscess were identified without a culture-proven amebic or fungal abscess. The mean age of diagnosis was 9.6 ± 6.2 years, and the male-to-female ratio was 1.92: 1. Hemato-oncological (28.9%) and predisposing hepatobiliary diseases (23.7%) were the two most common predisposing factors. Fever (94.7%) was the most common presentation followed by right upper quadrant abdominal pain (42.1%) and pleural effusion (34.2%). Among the laboratory parameters, leukocytosis was common (70.3%), and all patients had elevated serum C-reactive protein levels. Increased serum levels of alanine aminotransferase, aspartate aminotransferase, direct bilirubin, and total bilirubin were found in 40.5, 48.6, 23.1, and 42.9% of the cases, respectively. The most common pathogen in blood and pus cultures was Klebsiella pneumoniae. The mean durations of intravenous antibiotic and total antibiotic use were 29.0 ± 15.7 and 45.1 ± 22.1 days, respectively. Twelve patients (31.6%) were treated with antibiotics alone, while percutaneous needle aspiration, percutaneous pigtail drainage, and surgical intervention were performed in 12 (31.6%), 10 (26.3%), and 5 (13.2%) patients, respectively. No mortality was documented in this series.Conclusion: The present study reflects a relatively declining incidence of liver abscess compared with prior studies in Taiwan. K. pneumoniae remains the most prevalent pathogen in both blood and abscess cultures in Taiwan. Proper antimicrobial therapy with timely drainage generally yielded an adequate treatment response without any mortality.

Highlights

  • Liver abscess is an important yet relatively uncommon disease in children, with varied incidence and prevalence worldwide [1]

  • This was a retrospective study based on a review of medical records, enrolling pediatric patients who were diagnosed with a pyogenic liver abscess and hospitalized at Chang Gung Memorial Hospital Linkou branch between January 2000 and December 2019

  • A total of 53 cases with clinical suspicion and compatible ultrasonographic findings for liver abscess were collected initially; 11 cases were excluded by Computed tomography (CT) scan and four cases were excluded due to their inappropriateness for the data analysis: one referral case had incomplete medical records; one case with traumatic abdominal injury had a prolonged and complicated treatment course; and a pair of preterm infants had multiple prematurity-associated complications, a concurrent infection, an uncertain diagnosis and a prolonged antibiotics course

Read more

Summary

Introduction

Liver abscess is an important yet relatively uncommon disease in children, with varied incidence and prevalence worldwide [1]. A nationwide all-age analysis for pyogenic liver abscess in Taiwan revealed an increasing annual incidence from 1996 (11.15 per 100,000) to 2004 (17.59 per 100,000) [7], two pediatric single institution-based studies disclosed a decline from 20 per 100,000 pediatric admissions in 1979–1992 to 8.3 per 100,000 pediatric admissions in 1986–2001 [8, 9]. Subsequent analyses of the incidence of liver abscess in Taiwanese children is lacking in past decades. The demographics and clinical features of liver abscess may differ among regions. Liver abscess is an important but relatively rare disease in children. This study investigated the clinical characteristics of eligible patients at a referral tertiary center over the past two decades

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call